Effects of the hypnotic alkylphenol derivative propofol on breast cancer progression. a focus on preclinical and clinical studies

Research output: Contribution to journalReview articlepeer-review

Abstract

Propofol is a hypnotic alkylphenol derivative with many biological activities. It is predominantly used in anesthesia and is the most used parenteral anesthetic agent in the United States. Accumulating preclinical studies have shown that this compound may inhibit cancer recurrence and metastasis. Nevertheless, other investigations provided evidence that this compound may promote breast cancer cell progression by modulating different molecular pathways. Clinical data on this topic are scarce and derive from retrospective analyses. For this reason, we reviewed and evaluated the available data to reveal insight into this controversial issue. More preclinical and clinical investigations are necessary to determine the potential role of propofol in the proliferation of breast cancer cells.

Original languageEnglish
Pages (from-to)2513-2519
Number of pages7
JournalIn Vivo
Volume35
Issue number5
DOIs
Publication statusPublished - Oct 2021

Keywords

  • Breast cancer
  • Cancer migration
  • Cell proliferation
  • Intravenous anesthetic
  • Propofol
  • Review

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology

Fingerprint

Dive into the research topics of 'Effects of the hypnotic alkylphenol derivative propofol on breast cancer progression. a focus on preclinical and clinical studies'. Together they form a unique fingerprint.

Cite this